Preclinical platforms to study therapeutic efficacy of human γδ T cells-Reference-Cited by-同舟云学术

Preclinical platforms to study therapeutic efficacy of human γδ T cells

Published:2022-06 Issue:6 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Ou Lingling¹²,Wang Huaishan¹,Huang Hui³,Zhou Zhiyan³,Lin Qiang³,Guo Yeye¹,Mitchell Tara⁴,Huang Alexander C.⁴,Karakousis Giorgos⁵,Schuchter Lynn⁴,Amaravadi Ravi⁴,Guo Wei⁶,Salvino Joseph⁷,Herlyn Meenhard⁷,Xu Xiaowei¹

Affiliation:

1. Department of Pathology and Laboratory Medicine University of Pennsylvania Philadelphia Pennsylvania USA

2. Stomatological Hospital Southern Medical University Guangzhou China

3. The First Affiliated Hospital of Jinan University Guangzhou China

4. Department of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

5. Department of Surgery University of Pennsylvania Philadelphia Pennsylvania USA

6. Department of Biology University of Pennsylvania Philadelphia Pennsylvania USA

7. Molecular and Cellular Oncogenesis Program The Wistar Institute Philadelphia Pennsylvania USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.814

Reference54 articles.

1. Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

2. The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome

3. Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

4. Clinical Applications of Gamma Delta T Cells with Multivalent Immunity

5. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy;Clinical and Translational Medicine;2024-09

2. CAFs and T cells interplay: The emergence of a new arena in cancer combat;Biomedicine & Pharmacotherapy;2024-08

3. Patient-derived melanoma models;Pathology - Research and Practice;2024-07

4. Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research;Advanced Drug Delivery Reviews;2024-05

5. Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives;Experimental Hematology & Oncology;2024-04-23